US Patent Number

7595430

Publication Date

9-29-2009

Abstract

Methods for testing candidate drugs for treatment of age-related macular degeneration are provided. Ccl2-deficient, and Ccr2-deficient mice are used to determine the effect of candidate drugs and treatments on development of age-related macular degeneration. Also provided is a Ccl2-deficient, Ccr2-deficient dual knockout mouse, which is a useful animal model for age-related macular degeneration.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

10/685,705

Filing Date

10/16/2003

Included in

Ophthalmology Commons

Share

COinS